ANGIOEDEMA
Clinical trials for ANGIOEDEMA explained in plain language.
Never miss a new study
Get alerted when new ANGIOEDEMA trials appear
Sign up with your email to follow new studies for ANGIOEDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could tame stubborn hives when antihistamines fail
Disease control CompletedThis phase 2 trial tested an oral drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives and itching lasting months) that standard antihistamines couldn't control. Participants took either povorcitinib or a placebo for 12 weeks to see if the drug reduced…
Matched conditions: ANGIOEDEMA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New tablet shows promise for chronic hives in small study
Symptom relief CompletedThis study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives. Participants took one tablet before a main meal for 28 days. The study measured how well the tablet controlled hives, reduced symptoms, and improved quality of life. Results showed ch…
Matched conditions: ANGIOEDEMA
Phase: NA • Sponsor: OmniSolutions Laboratory Holdings Limited • Aim: Symptom relief
Last updated Jun 22, 2026 12:07 UTC